First international Phase III clinical trial of Covid-19 vaccine launched

On June 23, the inactivated vaccine international Clinical (Phase III) by Sinopharm Group’s China National Biotec Group (CNBG) was launched in Beijing and Wuhan of China, and Abu Dhabi of UAE, according to media reports.

On June 23, the inactivated vaccine international Clinical (Phase III) by Sinopharm Group’s China National Biotec Group (CNBG) was launched in Beijing and Wuhan of China, and Abu Dhabi of UAE, according to media reports.

It is held simultaneously in a video conference. The UAE Minister of Health issued a clinical trial approval document to CNBG.

At the ceremony, China and UAE signed relevant clinical cooperation agreements, marking the launch of the world’s first international clinical trial (Phase III) of the inactivated vaccine for Covid-19 virus.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/06/23/first-international-phase-iii-clinical-trial-of-covid-19-vaccine-launched/.

Leave a Reply

Please Login to Comment